http://www.x4pharma.com
X4 Pharmaceuticals, Inc. Company Intro
Our grit drives solutions for patients. Every day, we strive to advance our pipeline of innovative medicines to treat rare diseases. By targeting the CXCR4 pathway, our novel medicines are designed to restore healthy immunity in patients with rare diseases.
Industry
Healthcare
X4 Pharmaceuticals, Inc. Headquaters
955 Massachusetts Avenue
Cambridge,02139
United States
X4 Pharmaceuticals, Inc. Share price
17 May 2023 14:08 GMT
$1.7450
-0.01 (-0.85 %)
X4 Pharmaceuticals, Inc. Market cap
$239.47 M
WMC RANKING
2023
X4 Pharmaceuticals, Inc. # 226
BiotechnologyLatest X4 Pharmaceuticals, Inc. News
03 Oct 2023
X4 Pharmaceuticals Announces Inducement Grants Under ...
X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases of the immune system. Our lead...
03 Oct 2023
X4 Pharmaceuticals Announces Inducement Grants Under ...
X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases of the immune system. Our lead...
02 Oct 2023
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the...
WMC Market Score
WMC Market to Revenue Score
X4 Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| X4 Pharmaceuticals, Inc. | USD | $0 | $67,229 | $-77,908 | $2,395M | 226 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total X4 Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
X4 Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| X4 Pharmaceuticals, Inc. | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
